In the differential diagnosis with metastatic urothelial carcinoma of the urinary tract, the detection of an associated benign Brenner tumor component, as well as expression of CA125 and absence of cytokeratin 20, may be helpful to confirm a borderline Brenner tumor of primary ovarian origin. The gene discussed is KRT20; the disease is neoplasm.